Insider Buying Frenzy at ZoomInfo: CFO’s Latest Trade Signals Confidence
On April 1, 2026, CFO Michael Graham executed a sizable purchase of 1,554 common shares of ZoomInfo, matching a simultaneous buy of 224 and 765 shares in the same filing. The transaction, filed under Form 4, was conducted at the prevailing market price of $5.81—exactly the closing price for the day—indicating that the deal was likely executed in real time rather than at a pre‑approved discount. While the trade volume is modest relative to ZoomInfo’s total shares outstanding, it comes amid a broader pattern of consistent buying by the CFO, suggesting a steady belief in the company’s long‑term trajectory.
What Investors Should Take Note Of
ZoomInfo’s share price has slipped 25.26 % year‑to‑date, a decline that has rattled the market and prompted scrutiny of executive actions. The CFO’s purchase, however, contrasts sharply with the recent wave of sales by other senior officers—including James M. Roth’s 35 k‑share sale of restricted‑stock units and Ashley McGrane’s 6 k‑share sale. By buying shares while peers are divesting, Graham’s move may signal an internal confidence that the stock is undervalued or that the company’s upcoming initiatives—such as product‑expansion and strategic acquisitions—will lift valuation. For investors, this divergence can be a catalyst for a more nuanced assessment: a CFO’s stake increase is a positive governance signal, but it should be weighed against the broader context of price erosion and market sentiment.
Graham’s Insider‑Trading Footprint
A review of Graham’s transaction history shows a pattern of frequent, moderate purchases interspersed with large sell‑offs of restricted‑stock units. In February, he bought 26,378 shares and later sold 33,512 shares, while also liquidating significant R‑SU balances (71,777 units). In October, he accumulated 31,250 shares before selling 11,542 shares of R‑SUs. These actions demonstrate a typical “buy‑and‑hold” stance: he acquires common equity to support long‑term confidence while periodically monetizing vested RSUs to manage liquidity or tax obligations. The most recent April trade fits this cadence, reinforcing that the CFO views the current valuation as a buying opportunity rather than a short‑term speculative play.
Implications for ZoomInfo’s Future Outlook
ZoomInfo’s recent quarterly results reflected a modest revenue bump but a widening margin squeeze, partly due to heavy investment in data‑science tooling. The CFO’s purchase could be interpreted as a hedge against these headwinds, implying that he believes the company’s strategic investments will ultimately translate into higher earnings. If the market perceives this as credible, the stock may experience a short‑term rebound. However, sustained upside will require continued revenue acceleration and margin restoration, as the current 15.34 price‑earnings ratio remains above industry peers.
Bottom Line for Investors
Graham’s buy, while small in dollar terms, is a useful barometer of insider confidence. It contrasts sharply with the aggressive selling of other executives and may serve as a signal that the CFO expects a turnaround. For long‑term investors, it underscores a potential mispricing, especially given ZoomInfo’s low 52‑week low and current market cap of $1.77 billion. Coupled with the high social‑media buzz (550 % intensity) and neutral sentiment, the CFO’s trade could act as a catalyst for a modest rally—provided the company delivers on its growth promises.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-04-01 | O’Brien Michael Graham (CFO) | Buy | 1,554.00 | 0.00 | Common Stock |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Buy | 224.00 | 0.00 | Common Stock |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Buy | 765.00 | 0.00 | Common Stock |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Buy | 29,400.00 | 0.00 | Common Stock |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Buy | 7,813.00 | 0.00 | Common Stock |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Buy | 28,050.00 | 0.00 | Common Stock |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Sell | 18,054.00 | 5.98 | Common Stock |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Sell | 1,554.00 | N/A | Restricted Stock Units |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Sell | 224.00 | N/A | Restricted Stock Units |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Sell | 765.00 | N/A | Restricted Stock Units |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Sell | 7,813.00 | N/A | Restricted Stock Units |
| 2026-04-01 | O’Brien Michael Graham (CFO) | Sell | 28,050.00 | N/A | Restricted Stock Units |
| 2026-04-01 | HSKB Funds II, LLC () | Sell | 9,797.00 | N/A | Common Stock |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Buy | 782.00 | 0.00 | Common Stock |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Buy | 611.00 | 0.00 | Common Stock |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Buy | 552.00 | 0.00 | Common Stock |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Buy | 4,468.00 | 0.00 | Common Stock |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Buy | 33,000.00 | 0.00 | Common Stock |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Sell | 11,571.00 | 5.98 | Common Stock |
| 2026-04-02 | McGrane Ashley (General Counsel and Corp Sec) | Sell | 6,959.00 | 5.87 | Common Stock |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Sell | 782.00 | N/A | Restricted Stock Units |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Sell | 611.00 | N/A | Restricted Stock Units |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Sell | 552.00 | N/A | Restricted Stock Units |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Sell | 4,468.00 | N/A | Restricted Stock Units |
| 2026-04-01 | McGrane Ashley (General Counsel and Corp Sec) | Sell | 33,000.00 | N/A | Restricted Stock Units |
| 2026-04-01 | Schuck Henry (Chief Executive Officer) | Buy | 13,787.00 | 0.00 | Common Stock |
| 2026-04-01 | Schuck Henry (Chief Executive Officer) | Sell | 4,598.00 | 5.98 | Common Stock |
| N/A | Schuck Henry (Chief Executive Officer) | Holding | 237,376.00 | N/A | Common Stock |
| N/A | Schuck Henry (Chief Executive Officer) | Holding | 5,803,333.00 | N/A | Common Stock |
| 2026-04-01 | Schuck Henry (Chief Executive Officer) | Sell | 13,787.00 | N/A | Restricted Stock Units |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Buy | 4,464.00 | 0.00 | Common Stock |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Buy | 30,639.00 | 0.00 | Common Stock |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Buy | 22,059.00 | 0.00 | Common Stock |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Buy | 72,980.00 | 0.00 | Common Stock |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Sell | 58,696.00 | 5.98 | Common Stock |
| 2026-04-02 | Roth James M (Chief Revenue Officer) | Sell | 35,723.00 | 5.87 | Common Stock |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Sell | 4,464.00 | N/A | Restricted Stock Units |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Sell | 30,639.00 | N/A | Restricted Stock Units |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Sell | 22,059.00 | N/A | Restricted Stock Units |
| 2026-04-01 | Roth James M (Chief Revenue Officer) | Sell | 72,980.00 | N/A | Restricted Stock Units |




